Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Intimation of the Board Meeting scheduled to be held on 13.02.2025 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, inter alia, to consider, approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 3rd quarter/nine months ended on December 31, 2024 of the Financial Year 2024-25.
Sunil Healthcare Ltd. Press Release Feb 04 2025
Filed with BSE · · 1 page · English
Release
Earlier from Sunil Healthcare
- Sunil Healthcare Ltd. Press Release Jan 08 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Sunil Healthcare Ltd. Press Release Nov 22 2024
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
- Sunil Healthcare Ltd. Press Release Nov 15 2024
Later from Sunil Healthcare
- Un-Audited Financial Results (Standalone And Consolidated) For 3Rd Quarter/ Nine Months Ended December 31, 2024
- Board Meeting Outcome for Outcome Of The 262Nd Board Meeting Held On 13.02.2025
- Integrated Filing (Financial)
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Sunil Healthcare Ltd. Press Release Feb 13 2025
Follow Sunil Healthcare into a list and get an email when it puts out news.
Follow Sunil Healthcare